Advertisement
Document › Details
TxCell S.A.. (10/25/17). "Press Release: TxCell Renegotiates OCABSA Financing Option to Extend Cash Runway [Not for distribution in the United States of America, Canada, Australia and Japan]". Valbonne.
Organisation | TxCell S.A. (Euronext Paris: TXCL) | |
Organisation 2 | Yorkville Advisors Global L.P. | |
Group | Yorkville Group (Group) | |
Product | finance | |
Product 2 | T cell therapy | |
Person | Flipo, Raphaël (TxCell 201509 CFO) | |
Person 2 | Boissel, Stéphane (SparingVision 202010– CEO before Sangamo + TxCell + Genclis + Transgene + Innate Pharma + Lazard) | |
Original document
accessed by [iito] on 2017-10-26
Record changed: 2023-06-05 |
Advertisement
More documents for TxCell S.A. (Euronext Paris: TXCL)
- [1] Sangamo Therapeutics, Inc.. (7/23/18). "Press Release: Sangamo Therapeutics to Acquire TxCell". Richmond, CA & Valbonne....
- [2] TxCell S.A.. (7/9/18). "Press Release: TxCell Exercises In-license Option to the University of British Columbia's Intellectual Property Rights of the HLA-A2 CAR-Treg Program". Valbonne....
- [3] TxCell S.A.. (6/21/18). "Press Release: First in Vivo Proof-of-Concept Data with CD8+ CAR-Treg Presented at FOCIS 2018". Valbonne....
- [4] TxCell S.A.. (5/31/18). "Press Release: TxCell Names Lonza as Its CAR-Treg Cellular Product Manufacturer". Valbonne & Basel....
- [5] TxCell S.A.. (4/25/18). "Press Release: TxCell – Financial Information for the 1st Quarter of 2018 and Availability of the 2017 Registration Document (document de référence)". Valbonne....
- [6] TxCell S.A.. (1/17/18). "Press Release: TxCell Obtains Government Funding to Advance Its Lead CAR-Treg Program". Valbonne....
- [7] TxCell S.A.. (12/18/17). "Press Release: TxCell Completes CAR-Treg Manufacturing Process Development and Provides Update to CMO Selection". Valbonne....
- [8] TxCell S.A.. (10/19/17). "Press Release: Financial Information for the 3rd Quarter of 2017". Valbonne....
- [9] TxCell S.A.. (7/26/17). "Press Release: TxCell – Financial Information for the 2nd Quarter of 2017". Valbonne....
- [10] TxCell S.A.. (6/19/17). "Press Release: TxCell Appoints Lentigen Technology, Inc. to Manufacture the Lentiviral Vector for Its First CAR-Treg Program in Transplant Rejection". Valbonne....
To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«
Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]
Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)
Advertisement
» top